Symbiotics is the leading market access platform for impact investing, dedicated to private markets in emerging and frontier economies. The group offers investment, asset management and capacity building services. Since 2005, we have originated over 7,900 investments representing more than USD 10 billion for 598 companies in 97 countries. We manage an aggregate portfolio of USD 2.8 billion spread across 20 funds and mandates. Our portfolio companies have also benefited from over 170 technical assistance projects worth more than USD 19 million.